Skip to main content
. 2017 Aug 2;2017(8):CD001324. doi: 10.1002/14651858.CD001324.pub5

Comparison 10.

Mifepristone alone (all doses) versus mifepristone + tamoxifen (all doses)

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Observed number of pregnancies (all women) 1 400 Risk Ratio (M‐H, Fixed, 95% CI) 3.0 [0.31, 28.60]
2 Specific side effect 1 Risk Ratio (M‐H, Fixed, 95% CI) Subtotals only
2.1 Nausea 1 400 Risk Ratio (M‐H, Fixed, 95% CI) 0.74 [0.38, 1.43]
2.2 Vomiting 1 400 Risk Ratio (M‐H, Fixed, 95% CI) 2.0 [0.18, 21.88]
2.3 Headache 1 400 Risk Ratio (M‐H, Fixed, 95% CI) 3.0 [0.12, 73.20]
2.4 Dizziness 1 400 Risk Ratio (M‐H, Fixed, 95% CI) 5.0 [0.24, 103.49]
2.5 Fatigue 1 400 Risk Ratio (M‐H, Fixed, 95% CI) 1.17 [0.40, 3.41]
2.6 Breast tenderness 1 400 Risk Ratio (M‐H, Fixed, 95% CI) 0.5 [0.05, 5.47]
2.7 Diarrhoea 1 400 Risk Ratio (M‐H, Fixed, 95% CI) 3.0 [0.12, 73.20]
2.8 Spotting/bleeding after treatment 1 400 Risk Ratio (M‐H, Fixed, 95% CI) 0.71 [0.35, 1.44]
2.9 Abdominal pain 1 400 Risk Ratio (M‐H, Fixed, 95% CI) 3.0 [0.31, 28.60]
2.10 Heavy menses 1 396 Risk Ratio (M‐H, Fixed, 95% CI) 5.56 [1.25, 24.74]
3 Menses 1 Risk Ratio (M‐H, Fixed, 95% CI) Subtotals only
3.1 Delay 1 396 Risk Ratio (M‐H, Fixed, 95% CI) 1.79 [0.93, 3.43]